The Company will hold a conference call to discuss the results for the second quarter ended January 31, 2013 on Thursday, March 7, 2013 at 11:00 AM Eastern Time. To participate in the conference call, dial 1-877-407-8033 approximately 5 to 10 minutes before the beginning of the call. If you are unable to participate, a digital replay of the call will be available from Thursday, March 7, 2013 at 2:00 PM through midnight on May 7, 2013 by dialing 1-877-660-6853 and using conference ID #410008.
The call will be simultaneously broadcast live over the Internet on vcall.com at http://www.investorcalendar.com/IC/CEPage.asp?ID=170630. A replay of the webcast will be available on Vcall for 90 days.
For further information, visit the Cantel website at www.cantelmedical.com.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including, without limitation, the risks detailed in Cantel's filings and reports with the Securities and Exchange Commission. Such forward-looking statements are only predictions, and actual events or results may differ materially from those projected or anticipated.
CANTEL MEDICAL CORP. CONDENSED CONSOLIDATED STATEMENTS OF INCOME(In thousands, except per share data)(unaudited)Three Months EndedSix Months EndedJanuary 31,January 31,2013201220132012Net sales$ 106,363$
97,297$ 206,044$ 190,559Cost of sales61,21256,476117,166111,788Gross profit45,15140,82188,87878,771Expenses: Selling13,72313,27027,13626,193 General and administrative12,38212,09224,43024,194 Research and development2,1832,2984,4774,443Total operating expenses28,28827,66056,04354,830I
|SOURCE Cantel Medical Corp.|
Copyright©2012 PR Newswire.
All rights reserved